The Monash center in Melbourne has become the first in Australia to use SD-IORT, during a clinical trial in the country. A woman with early-stage breast cancer became the first patient to receive a single, concentrated dose of intraoperative radiation therapy (IORT) at the time of surgery. The single dose of radiotherapy is delivered in just one 8 minute session, compared to six to eight weeks of treatment which is the standard radiation therapy option.
Using the Xoft System, oncologists and surgeons work together during a wide local excision to deliver a concentrated high dose of low energy radiation, administered through a small balloon shaped applicator inserted into the breast cavity created by the surgery. This allows the radiation to be delivered directly to the tumour bed whilst preserving nearby healthy tissue. The Xoft system uses low energy X-rays instead of radioactive isotopes to deliver IORT, allowing medical personnel to remain in the room with the patient.
“Intraoperative radiotherapy will offer women with early-stage breast cancer another therapeutic option, and, we believe, a better patient experience with less treatment morbidity, and a more rapid return to normal activity,” said Jane Fox, director of breast services at Monash Health. “We are encouraged by the research to date as the global community of treatment centers continues to provide appropriate patients with the unique option to complete a full dose of radiation therapy in a single treatment.”